In this systematic review, we investigate the epidemiology, pathogenesis, risk factors, clinical
manifestations, diagnosis and treatment of COVID-19-associated pulmonary aspergillosis …

Purpose Invasive pulmonary aspergillosis has been increasingly recognized in COVID-19
patients, termed COVID-19-associate pulmonary aspergillosis (CAPA). Our meta-analysis …

Objectives Information on the recently COVID‐19‐associated pulmonary aspergillosis
(CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU …

Abstract COVID‐19‐associated pulmonary aspergillosis (CAPA) has been reported
worldwide. However, basic epidemiological characteristics have not been well established …

Summary COVID-19-associated pulmonary aspergillosis (CAPA) is defined as invasive
pulmonary aspergillosis occurring in COVID-19 patients. The purpose of this review was to …

First reports of cases and case series of COVID-19-associated pulmonary aspergillosis
(CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely …

Invasive Pulmonary Aspergillosis (IPA) has been recognized as a possible secondary
infection complicating Coronavirus disease 2019 (COVID-19) and increasing mortality. The …

Background COVID-19-associated pulmonary aspergillosis (CAPA) has been reported to be
an emerging and potentially fatal complication of severe COVID-19. However, risk factors for …

Further studies are needed to validate CAPA case definitions, to determine the accurate
incidence of CAPA in comparison to adequate controls, and its evolution during the …

Our study aims to assess the prevalence of CAPA (COVID-19-associated pulmonary
aspergillosis) and describe the associated risk factors and their impact on mortality. A …